ICL Change To Account Receivables from 2010 to 2025

ICL Stock  USD 5.69  0.13  2.23%   
ICL Israel Change To Account Receivables yearly trend continues to be quite stable with very little volatility. Change To Account Receivables may rise above about 27.3 M this year. From the period between 2010 and 2025, ICL Israel, Change To Account Receivables regression line of its data series had sample variance of 39359.6 T and sample variance of 39359.6 T. View All Fundamentals
 
Change To Account Receivables  
First Reported
2001-09-30
Previous Quarter
42 M
Current Value
68 M
Quarterly Volatility
140.8 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ICL Israel financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ICL Israel's main balance sheet or income statement drivers, such as Depreciation And Amortization of 625.8 M, Interest Expense of 121.3 M or Selling General Administrative of 367.1 M, as well as many indicators such as Price To Sales Ratio of 1.86, Dividend Yield of 0.0413 or PTB Ratio of 1.06. ICL financial statements analysis is a perfect complement when working with ICL Israel Valuation or Volatility modules.
  
Check out the analysis of ICL Israel Correlation against competitors.

Latest ICL Israel's Change To Account Receivables Growth Pattern

Below is the plot of the Change To Account Receivables of ICL Israel Chemicals over the last few years. It is ICL Israel's Change To Account Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ICL Israel's overall financial position and show how it may be relating to other accounts over time.
Change To Account Receivables10 Years Trend
Very volatile
   Change To Account Receivables   
       Timeline  

ICL Change To Account Receivables Regression Statistics

Arithmetic Mean(17,590,153)
Coefficient Of Variation(1,128)
Mean Deviation149,525,280
Median21,758,087
Standard Deviation198,392,634
Sample Variance39359.6T
Range704M
R-Value(0)
Mean Square Error42170.8T
R-Squared0.0000047
Significance0.99
Slope(90,304)
Total Sum of Squares590394.6T

ICL Change To Account Receivables History

202527.3 M
202426 M
2023278 M
2022-215 M
2021-426 M
2020-89 M
2019199 M

About ICL Israel Financial Statements

ICL Israel investors utilize fundamental indicators, such as Change To Account Receivables, to predict how ICL Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Change To Account Receivables26 M27.3 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether ICL Israel Chemicals is a strong investment it is important to analyze ICL Israel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ICL Israel's future performance. For an informed investment choice regarding ICL Stock, refer to the following important reports:
Check out the analysis of ICL Israel Correlation against competitors.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.087
Dividend Share
0.193
Earnings Share
0.32
Revenue Per Share
5.303
Quarterly Revenue Growth
(0.05)
The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.